Details for New Drug Application (NDA): 017766
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
NDA 017766 describes NEPHRAMINE 5.4%, which is a drug marketed by B Braun and is included in one NDA. Additional details are available on the NEPHRAMINE 5.4% profile page.
The generic ingredient in NEPHRAMINE 5.4% is amino acids. There are three hundred and fifty drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the amino acids profile page.
The generic ingredient in NEPHRAMINE 5.4% is amino acids. There are three hundred and fifty drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the amino acids profile page.
Summary for 017766
| Tradename: | NEPHRAMINE 5.4% |
| Applicant: | B Braun |
| Ingredient: | amino acids |
| Patents: | 0 |
| Formulation / Manufacturing: | see details |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 5.4% (5.4GM/100ML) | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
